PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Actinium Pharmaceuticals, Inc. (ATNM)
1.780.01 (-0.56%)
1.75 - 1.81
1.03 - 2.41
122.5K / 296.7K (Avg.)
-1.36 | -1.31
Helps investors judge whether earnings growth is driven by sustainable operations or temporary factors. Consistent, organic income expansion can justify a higher intrinsic value for patient, long-term investors.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-41.39%
G&A reduction while Healthcare median is 0.00%. Seth Klarman would investigate efficiency gains.
No Data
No Data available this quarter, please select a different quarter.
15.06%
Other expenses change of 15.06% versus flat Healthcare costs. Walter Schloss would verify efficiency.
-38.60%
Operating expenses reduction while Healthcare median is 0.00%. Seth Klarman would investigate advantages.
-38.60%
Total costs reduction while Healthcare median is 0.00%. Seth Klarman would investigate advantages.
10.73%
Interest expense change of 10.73% versus flat Healthcare costs. Walter Schloss would verify control.
No Data
No Data available this quarter, please select a different quarter.
38.60%
EBITDA change of 38.60% versus flat Healthcare. Walter Schloss would verify quality.
No Data
No Data available this quarter, please select a different quarter.
38.60%
Income change of 38.60% versus flat Healthcare. Walter Schloss would verify quality.
No Data
No Data available this quarter, please select a different quarter.
-122.72%
Other expenses reduction while Healthcare median is 0.00%. Seth Klarman would investigate advantages.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-30.20%
Tax expense reduction while Healthcare median is 0.00%. Seth Klarman would investigate advantages.
30.20%
Income change of 30.20% versus flat Healthcare. Walter Schloss would verify quality.
No Data
No Data available this quarter, please select a different quarter.
30.24%
EPS change of 30.24% versus flat Healthcare. Walter Schloss would verify quality.
30.24%
Diluted EPS change of 30.24% versus flat Healthcare. Walter Schloss would verify quality.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.